Target |
Mechanism PPARγ agonists [+1] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date29 Aug 2005 |
Target |
Mechanism PPARγ agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date10 Oct 2002 |
Target |
Mechanism PPARα agonists [+2] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date20 Nov 2023 |
Sponsor / Collaborator |
Start Date18 Nov 2023 |
Sponsor / Collaborator |
Start Date14 Nov 2023 |
Sponsor / Collaborator |